OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants
Mauro Cataldi, Vincenzo Citro, Chiara Resnati, et al.
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2094-2113
Open Access | Times Cited: 7
Mauro Cataldi, Vincenzo Citro, Chiara Resnati, et al.
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2094-2113
Open Access | Times Cited: 7
Showing 7 citing articles:
Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects
A. Feldman, Bernhard Wernly, Georg Strebinger, et al.
Journal of Gastrointestinal and Liver Diseases (2021) Vol. 30, Iss. 3, pp. 366-373
Open Access | Times Cited: 31
A. Feldman, Bernhard Wernly, Georg Strebinger, et al.
Journal of Gastrointestinal and Liver Diseases (2021) Vol. 30, Iss. 3, pp. 366-373
Open Access | Times Cited: 31
Human placental extract ameliorates methotrexate-induced hepatotoxicity in rats via regulating antioxidative and anti-inflammatory responses
Mamdooh Ghoneum, Mohamed S.A. El-Gerbed
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 6, pp. 961-971
Open Access | Times Cited: 25
Mamdooh Ghoneum, Mohamed S.A. El-Gerbed
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 6, pp. 961-971
Open Access | Times Cited: 25
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
Laura Giuseppina Di Pasqua, Marta Cagna, Clarissa Berardo, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 194-194
Open Access | Times Cited: 13
Laura Giuseppina Di Pasqua, Marta Cagna, Clarissa Berardo, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 194-194
Open Access | Times Cited: 13
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease
Tatjana Zekić, Mirjana Stanić Benić, Mislav Radić
Rheumatology International (2022) Vol. 42, Iss. 10, pp. 1665-1679
Closed Access | Times Cited: 7
Tatjana Zekić, Mirjana Stanić Benić, Mislav Radić
Rheumatology International (2022) Vol. 42, Iss. 10, pp. 1665-1679
Closed Access | Times Cited: 7
Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population‐based cohort study
C. C. Laura Meng, Der‐Yuan Chen, Yi‐Hsing Chen, et al.
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Closed Access | Times Cited: 3
C. C. Laura Meng, Der‐Yuan Chen, Yi‐Hsing Chen, et al.
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Closed Access | Times Cited: 3
Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
Mauro Cataldi, Federica Manco, Giovanni Tarantino
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12947-12947
Open Access | Times Cited: 6
Mauro Cataldi, Federica Manco, Giovanni Tarantino
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12947-12947
Open Access | Times Cited: 6
Non-Alcoholic Fatty Liver Disease : Insights into Alcohol Consumption, Genetics, and Proteomics
Julia Blomdahl
Linköping University medical dissertations (2023)
Open Access
Julia Blomdahl
Linköping University medical dissertations (2023)
Open Access
